Favanya effect on intractable epilepsy in children

The effect of herbal products Paeonia on the Treatment of children with refractory epilepsy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131125015533N2

Enrollment

Registered

2018-12-06

Start date

2018-12-06

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intractable epilepsy in children. Attack with loss of consciousness

Interventions

Intervention group: Administration of paeonia officinalis hydroalcoholic extract as an oral solution of 20 mg / kg three times a day for four weeks.

Eligibility

Sex/Gender

All

Age

1 Years to 14 Years

Inclusion criteria

Inclusion criteria: true drug-resistant epilepsy Age range 1 to 14 years Conscious written consent from parents

Exclusion criteria

Exclusion criteria: Presence of degenerative nerve disease History of false seizures The presence of chronic disease

Design outcomes

Primary

Measure	Time frame
Number of epileptic seizures; severity of epilepsy. Timepoint: At the beginning of the study, 7, 14, 21 and 28 days later. Method of measurement: questionnaire.	—

Secondary

Measure	Time frame
Side effects. Timepoint: 7, 14, 21 and 28 days after taking the drug. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad zangoueipourfard

Mashhad University of Medical Sciences

zangoueipm941@mums.ac.ir+98 51 3606 1446

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 22, 2026